$0.66 1.5%
KZR Stock Price vs. AI Score (Last 150 days)
Data gathered: June 25

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Kezar Life Sciences

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.

Kezar Life Sciences
Price $0.66
Target Price Sign up
Volume 580,210
Market Cap $47M
Year Range $0.64 - $1.05
Dividend Yield 0%
Revenue per Employee $14,000
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2406.5M-6.9M-22M-23M-0.300
Q4 '23-5.4M14M-14M-32M-28M-0.440
Q3 '236.6M8.8M-2.2M-23M-26M-0.320
Q2 '2305.8M-6.2M-24M-24M-0.340
Q1 '2306.2M-6.6M-22M-22M-0.310

Insider Transactions View All

Morningside Venture Investments Ltd filed to sell 5,447,993 shares at $6.9.
February 7 '23
Morningside Venture Investments Ltd filed to sell 5,487,993 shares at $7.1.
February 7 '23
Morningside Venture Investments Ltd filed to sell 5,512,993 shares at $7.2.
February 3 '23
Morningside Venture Investments Ltd filed to sell 5,562,993 shares at $7.
February 3 '23
Morningside Venture Investments Ltd filed to sell 5,602,993 shares at $7.1.
February 1 '23

What is the Market Cap of Kezar Life Sciences?

The Market Cap of Kezar Life Sciences is $47M.

How Many People Work at Kezar Life Sciences?

As of our latest update, Kezar Life Sciences employed approximately 84 people worldwide. However, it's important to note that Kezar Life Sciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Kezar Life Sciences' revenue per employee?

$14,000. To calculate Kezar Life Sciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Kezar Life Sciences?

Currently, the price of one share of Kezar Life Sciences stock is $0.66.

How can I analyze the KZR stock price chart for investment decisions?

The KZR stock price chart above provides a comprehensive visual representation of Kezar Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Kezar Life Sciences shares. Our platform offers an up-to-date KZR stock price chart, along with technical data analysis and alternative data insights.

Does KZR offer dividends to its shareholders?

As of our latest update, Kezar Life Sciences (KZR) does not offer dividends to its shareholders. Investors interested in Kezar Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Kezar Life Sciences?

Some of the similar stocks of Kezar Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.